Heyu Biological Technology Corporation
HYBT · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$472 | -$379 | -$266 | -$163 |
| Dep. & Amort. | $91 | $88 | $0 | $0 |
| Deferred Tax | -$22 | -$66 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | $0 | $0 | -$27 | $22 |
| Other Non-Cash | -$6,933 | $0 | $0 | $0 |
| Operating Cash Flow | -$7,338 | $751 | -$292 | -$141 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$4,022 | -$40,596 | $0 | $0 |
| Net Acquisitions | -$567 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $1,085 | -$1,083 | $0 | $0 |
| Investing Cash Flow | -$3,504 | -$41,679 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $10,205 | $40,942 | $196 | $162 |
| Financing Cash Flow | $10,205 | $40,942 | $196 | $162 |
| Forex Effect | $0 | $0 | $103 | -$22 |
| Net Chg. in Cash | -$655 | $893 | $7 | -$1 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $896 | $3 | $4 | $5 |
| End Cash | $241 | $896 | $11 | $4 |
| Free Cash Flow | -$11,360 | -$39,846 | -$292 | -$141 |